Fulcrum Therapeutics (FULC) Other financing activities (2019 - 2020)
Fulcrum Therapeutics (FULC) posted quarterly Other financing activities of -$158000.0 for Q3 2020, up 41.48% quarter-over-quarter from -$270000.0 in Q4 2019.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Other financing activities (2019 - 2020) Analysis & Trends
Fulcrum Therapeutics (FULC) has reported Other financing activities for 2 consecutive years, with -$158000.0 the latest figure, recorded in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Fulcrum Therapeutics | 293.24 Mn | 293.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -158,000.00 |
| Dec 31, 2019 | -270,000.00 |